Pulse Biosciences (PLSE) Total Current Liabilities (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Total Current Liabilities of $7.9 million for Q4 2025, down 21.2% year-over-year from $10.1 million in Q4 2024, and down 18.32% quarter-over-quarter from $9.7 million in Q3 2025.
Pulse Biosciences (PLSE) Total Current Liabilities (2015 - 2026) Analysis & Trends
Pulse Biosciences' Total Current Liabilities history runs 11 years deep, the most recent figure standing at $7.9 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 21.2% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $7.9 million (down 21.2% YoY), while the FY2025 annual figure was $7.9 million, down 21.2% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $7.9 million, down from $9.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $10.1 million in Q4 2024, with the low at $5.1 million in Q1 2024.
- The 5-year median for Total Current Liabilities is $7.3 million (2022), against an average of $7.5 million.
- The sharpest annual moves came in 2021 and 2024: Total Current Liabilities soared 152.08% in 2021, then retreated 27.32% in 2024.
- Pulse Biosciences' Total Current Liabilities stood at $6.7 million in 2021, then fell by 10.84% to $6.0 million in 2022, then advanced by 12.16% to $6.7 million in 2023, then surged by 49.9% to $10.1 million in 2024, then dropped by 21.2% to $7.9 million in 2025.
- Business Quant data shows PLSE's Total Current Liabilities at $7.9 million in Q4 2025, $9.7 million in Q3 2025, and $9.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Pulse Biosciences | 3.33 Bn | 3.33 Bn | 161,000.00 | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.98 Mn |
| Dec 31, 2025 | 7.92 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 8.98 Mn |
| Mar 31, 2025 | 7.76 Mn |
| Dec 31, 2024 | 10.06 Mn |
| Sep 30, 2024 | 6.74 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 6.99 Mn |
| Dec 31, 2022 | 5.98 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Jun 30, 2022 | 7.56 Mn |
| Mar 31, 2022 | 8.91 Mn |
| Dec 31, 2021 | 6.71 Mn |
| Sep 30, 2021 | 9.52 Mn |
| Jun 30, 2021 | 9.84 Mn |